United States Food and Drug Administration, Silver Spring, MD 20993, USA.
Regul Toxicol Pharmacol. 2012 Apr;62(3):471-3. doi: 10.1016/j.yrtph.2012.02.001. Epub 2012 Feb 7.
As a first step in the implementation of the Food and Drug Administration's (FDA) Pathway to Global Product Safety and Quality (Anonymous, 2011), FDA's Office of International Programs (OIP) and the National Center for Toxicological Research (NCTR) sponsored a Global Summit on Regulatory Science Research and Innovation. Through a series of presentations and panel discussions, the Global Summit participants explored how research could be used more effectively as a tool for advancing regulatory science, food safety, medical technologies, and public health. Speakers provided an overview of each of the components in the global regulatory-science research initiative, including scientific innovation and modernizing toxicology; and discussed how the integration of these components is needed to achieve the promise of regulatory science at the global level. All participants agreed with the formation of a Global Coalition of Regulatory Research Scientists who will work collaboratively to build knowledge, promote the development of regulatory science, discover novel ways to clearly define research needs, and improve public health.
作为食品和药物管理局（FDA）全球产品安全和质量途径实施的第一步（Anonymous，2011），FDA 的国际项目办公室（OIP）和国家毒理学研究中心（NCTR）赞助了一次监管科学研究和创新全球峰会。通过一系列演讲和小组讨论，全球峰会参与者探讨了如何更有效地将研究用作推进监管科学、食品安全、医疗技术和公共卫生的工具。演讲者概述了全球监管科学研究倡议的各个组成部分，包括科学创新和毒理学现代化；并讨论了如何整合这些组成部分以实现全球监管科学的承诺。所有与会者都同意成立一个全球监管研究科学家联盟，该联盟将共同努力建立知识，促进监管科学的发展，发现明确研究需求的新方法，并改善公共卫生。
